Zurich, Switzerland
Completed
NCT Number: NCT00742794
Frequency of Hymenoptera-stings in Patients Under Allergen-Specific Immunotherapy (SIT)
In Switzerland, 3.5% of the population are suffering from hymenoptera venom allergy. The only causal treatment of hymenoptera alelrty is venom specific immunotherapy. There are however several reasons, which question the relatively broad application of this expensive treatment. That's why we aim at investigating the actual risk for hymenoptera stings in patients undergoing allergen specific immunotherapy against hymenoptera sting allergy
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
5 year–90 year
Sex eligibility
All sexes
Study type
Observational
Primary location
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Bee and/or Wasp allergic patients treated by SIT
Exclusion criteria
- None
Treatment and study plan
observation
OtherObservation of sting frequency
Sponsors and collaborators
Lead sponsor
University of Zurich
Other
Registry information
Official study title
Frequency of Hymenoptera-stings in Patients Under and After Allergen-specific Immunotherapy: a Retrospective Data-analysis Considering Socio-economic Aspects
Acronym: ZU-HVA-001
Important dates
- Study start
- 2008
- Study completion
- 2010
- First posted
- Aug 28, 2008
- Registry last updated
- Aug 19, 2010
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.